DUBLIN--(BUSINESS WIRE)--The "Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (Mass Spectrometry, Chromatography), Carbohydrates, Reagents & Chemicals), Application (Disease Diagnostics), End-User (Academic) - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.
Increasing R&D investments in pharmaceutical companies is a major factor driving the growth of the glycomics market.
The growth of this market is majorly driven by the increasing R&D expenditure and funding for proteomics and glycomics research, growth of the proteomics market, and technological advancements in glycomics instrumentation. However, the high cost of tools is expected to be the major challenge for the growth of the global glycomics market during the forecast period.
Academic research institutes segment accounted for the largest share of the glycomics market, by end-user, in 2019.
Based on end-user, the glycomics market is segmented into academic research institutes, pharmaceutical and biotechnology companies, and clinical laboratories. Academic research institutes are estimated to be the largest end-users of glycomics products in 2020. This end-user segment is also projected to grow at the highest CAGR during the forecast period. The large share and high growth of this end-user segment can be attributed to factors such as the increasing number of research activities on drug discovery, rising funding for glycomics research, and increasing number of collaborations for developing carbohydrate-based drugs.
Enzymes segment to register the highest growth in the glycomics market during the forecast period.
Based on the products, the glycomics market is categorized into five product segments, namely, enzymes, instruments, kits, carbohydrates, and reagents & chemicals. The enzymes segment is expected to dominate the market in 2020 and is projected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the consumable nature of enzymes and their wide applications in a variety of R&D and drug discovery procedures.
North America will continue to dominate the glycomics market during the forecast period.
Geographically, the global glycomics market is segmented into North America (US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, and the Rest of Asia Pacific), and the Rest of the World (Latin America and the Middle East and Africa). In 2020, North America is expected to dominate the global glycomics market. This is mainly due to increasing funding for research on glycomics, rising R&D investments for drug discovery & development, and the presence of key players in the region.
Key Benefits of Buying the Report:
This report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall glycomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. Also, this report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.
Key Topics Covered:
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
2 Research Methodology
2.1 Research Data
2.2 Secondary Data
2.3 Primary Data
2.4 Market Size Estimation
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Glycomics Market Overview
4.2 Market, By Product, 2020 Vs. 2025 (USD Million)
4.3 Asia Pacific: Market, By Product and Country
4.4 Market: Geographic Snapshot
5 Market Overview
5.2 Market Dynamics
6 Glycomics Market, By Product
6.6 Reagents & Chemicals
7 Glycomics Market, By Application
7.2 Drug Discovery & Development
7.3 Disease Diagnostics
8 Glycomics Market, By End User
8.2 Academic Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Clinical Laboratories
9 Glycomics Market, By Region
9.2 North America
9.3 Asia Pacific
9.4 Rest of the World
10 Competitive Landscape
10.2 Market Share Analysis, 2018
10.3 Key Strategies
10.4 Competitive Leadership Mapping (2018)
11 Company Profiles
11.1 Merck KGaA
11.2 Thermo Fisher Scientific
11.3 Takara Bio, Inc.
11.4 New England Biolabs
11.5 S-Bio (Subsidiary of Sumitomo Bakelite Co., Ltd.)
11.6 Asparia Glycomics S.L.
11.7 Agilent Technologies
11.9 Shimadzu Corporation
11.10 Bruker Corporation
11.11 Waters Corporation
11.12 AB Sciex Pte. Ltd. (Subsidiary of Danaher Corporation)
11.13 Raybiotech, Inc.
11.14 Z Biotech, Llc.
11.15 Chemily Glycoscience
11.16 Dextra Laboratories Ltd.
11.17 Lectenz Bio
11.18 Ludger Ltd.
11.19 Valiant Co., Ltd.
11.20 Sanyo Fine Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/reports/5005541/glycomicsglycobiology-market-by-product-enzymes?utm_source=dynamic&utm_medium=BW&utm_code=bgt56m&utm_campaign=1364968+-+Global+Glycomics+Market+is+Projected+to+Reach+USD+2.0+Billion+by+2025+from+USD+1.0+Billion+in+2020&utm_exec=anwr281bwd